U.S. Wireless Telecom Stock News

If you are wondering whether Morgan Stanley at around US$181 per share still offers value or is starting to look stretched, the key is to separate price excitement from underlying worth. The stock's recent returns, including 8.8% over 7 days, 17.0% over 30 days and 70.5% over 1 year, along with a relatively flat year to date move of a 0.4% decline, suggest the market has been reassessing the story over different time frames. Recent coverage has focused on Morgan Stanley as a major global...

Wondering if Jefferies Financial Group, at around US$46 per share, still offers value or if most of the opportunity is already reflected in the price. The stock has moved sharply in the short term, with a 10.1% return over 7 days and 27.1% over 30 days, set against a year-to-date return of a 27.2% decline and a 1-year return of 8.7% that sits within a longer 3-year return of 60.7% and 5-year return of 71.7%. These moves sit alongside ongoing interest in capital markets and corporate...

Some The Gap, Inc. ( NYSE:GAP ) shareholders may be a little concerned to see that the Executive VP & Chief People...

Fastenal (FAST) just posted its Q1 2026 scorecard, with recent quarterly numbers showing Q4 2025 revenue of about US$2.0b and basic EPS of US$0.26, alongside trailing twelve month basic EPS of US$1.10 on revenue of roughly US$8.2b. The company has seen revenue move from US$1.82b in Q4 2024 to about US$2.03b in Q4 2025, while quarterly basic EPS shifted from US$0.23 to US$0.26 over the same period, setting up this latest report against a backdrop of steady top line and per share earnings. With...

Altria Group (NYSE:MO) is rolling out its on! PLUS nicotine pouches nationally across the U.S. on! PLUS is the first product cleared under the FDA's pilot accelerated review program for tobacco products. The launch comes as competition in the U.S. nicotine market intensifies and regulatory oversight stays active. Altria is best known for its U.S. cigarette and oral tobacco businesses, and the on! PLUS launch signals a stronger push into smoke free nicotine products. The FDA's pilot...

Representative April McClain Delaney recently bought shares of Martin Marietta Materials (NYSE:MLM). The transaction involves a sitting member of Congress, drawing attention to the company and its current valuation. The purchase comes as Martin Marietta Materials trades around $635.29 per share. Martin Marietta Materials, trading on the NYSE under the ticker MLM, sits at a share price of about $635.29. The stock has returned 6.2% over the past week, 8.8% over the past month, and 27.0% over...

Fresh Del Monte Produce (NYSE:FDP) recently reported strong quarterly earnings, highlighting solid profitability in the most recent period. At the same time, the company continues to face long running revenue stagnation, a weaker revenue outlook, and structural profitability pressures. These mixed signals are raising questions about how sustainable the latest results may be without deeper business changes. Fresh Del Monte Produce, a global supplier of fresh and fresh cut fruits and...

Floor & Decor Holdings (FND) is drawing investor attention after opening a new warehouse store and design center in the Portland metro area, extending its footprint beyond 270 warehouse-format locations nationwide. See our latest analysis for Floor & Decor Holdings. While the new Portland warehouse highlights ongoing expansion, the share price tells a different story, with a 30 day share price return of an 11.93% decline and a 1 year total shareholder return of a 31.27% decline. This suggests...

Institutional interest and shareholder proposals come into focus Pzena Investment Management’s disclosure of an 11.3% stake in Amdocs (NasdaqGS:DOX), alongside proposals for a higher quarterly dividend and an expanded Employee Share Purchase Plan, has drawn fresh attention to the stock’s current setup for shareholders. See our latest analysis for Amdocs. At a share price of US$64.94, Amdocs has seen a 3.1% 1 day share price return but a 21.6% 90 day share price return decline, while the 1...

In late March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, incorporating both the Catalent Indiana facility and a second U.S.-based fill-finish site in line with recent agency guidance. This resubmission, following a prior Complete Response Letter tied to manufacturing inspections rather than apitegromab itself, shifts regulatory focus back to the drug’s clinical profile and supply-chain readiness...

Ecovyst recently reported quarterly earnings that came in ahead of analyst expectations and issued full-year 2026 EPS guidance in the US$0.45–US$0.65 range, prompting several brokerages to reaffirm or upgrade their views on the company’s outlook. This combination of an earnings beat and clearer profit guidance has sharpened the focus on how Ecovyst’s fundamentals align with assessments that its shares may be trading at a premium to intrinsic value. We’ll now explore how Ecovyst’s...

In April 2026, Natera highlighted interim futility analysis from Allogene Therapeutics’ registrational ALPHA3 trial, where its off‑the‑shelf anti‑CD19 CAR T candidate cema‑cel achieved molecular residual disease clearance in a majority of treated large B‑cell lymphoma patients and showed deep reductions in plasma ctDNA compared with observation alone. Because ALPHA3 is the first MRD‑guided randomized trial in this lymphoma setting, these early data not only support cema‑cel’s potential role...

Event context and recent share performance PDF Solutions (PDFS) has drawn attention after a recent move in its share price, with the stock last closing at US$40.66 and showing positive returns over the past week and month. Investors are also weighing the longer term picture, including a total 1 year return above 100% alongside relatively flat 3 year performance, as they reassess expectations for this semiconductor software and services provider. See our latest analysis for PDF Solutions. The...

Insider selling puts Harrow (HROW) under the microscope Heavy insider selling at Harrow (HROW) has caught investor attention after company insiders sold about US$8.1 million of stock over the past 3 months, with no reported insider purchases. This activity comes as Harrow shares recently fell 3.6% to US$35.93. At the same time, external models such as GuruFocus’s GF Value suggest the stock may be modestly undervalued, creating a tension between insider behavior and valuation signals. See our...

GPGI (GPGI) is back in focus after a relief rally tied to delayed U.S. military action in the Middle East faded, and attention shifted to its recent earnings and revenue shortfall. See our latest analysis for GPGI. That relief rally has now given way to renewed selling pressure, with the share price at US$16.39 and recent 7 day and 90 day share price returns of 5.04% and 23.52% declines. At the same time, 1 year and 3 year total shareholder returns of 53.26% and 169.35% point to a much...

ATRenew (RERE) is back in focus after AI driven models downgraded the stock, citing negative operating cash flow, compressed gross margins, weak technical signals, and a valuation that appears elevated relative to current profitability. See our latest analysis for ATRenew. Despite the downgrade, ATRenew’s recent 1 day share price return of 5.38% to US$4.70 and 7 day share price return of 5.15% sit against a weaker 30 and 90 day share price trend. At the same time, the 1 year total shareholder...

In the past few days, ICL Group reported stronger-than-expected first-quarter 2024 results, with its specialty minerals segment outperforming and broader fertilizer markets showing signs of potash and phosphate price stabilization. This combination of operational outperformance and easing commodity price pressure has reinforced investor confidence in the company’s recovery prospects amid ongoing geopolitical supply concerns. We’ll now examine how this earnings beat, particularly in specialty...

ICU Medical, Inc. recently held its 2026 Annual Meeting of Stockholders, where investors voted on amendments to adopt simple majority voting and to allow shareholders owning at least 25% of the company’s voting power to call special meetings, contingent on related bylaw changes becoming effective after filing in Delaware. At the same time, the board urged investors to oppose a separate shareholder proposal to lower the special-meeting ownership threshold to 10%, highlighting an active debate...

In early April 2026, PowerBridge LLC announced it had entered into a lease development agreement with LandBridge Company LLC, securing the option to lease up to 3,400 acres in Reeves County, Texas for a giga-scale data center campus with as much as 2 GW of initial co-located power generation and associated private power infrastructure under development. This potential “Alpha Digital Campus” adds a large-scale digital infrastructure and power project to LandBridge’s Permian footprint,...

The Cheesecake Factory recently rolled out a new mobile app tied to its Cheesecake Rewards program, offering members a free slice of any cheesecake or layer cake with any purchase for downloads and logins completed between April 1 and April 30, 2026. By marrying a generous, time-limited giveaway with its nationwide loyalty platform, the company is using digital engagement to deepen customer relationships and potentially increase visit frequency. Next, we’ll examine how this push into...

Foresight Financial Group (FGFH) has just posted Q4 2025 numbers that cap off a softer year, with total revenue of US$3.3 million, basic EPS of US$0.70 and trailing twelve month revenue of US$46.5 million translating into EPS of US$2.18. Over the past year, total revenue on a trailing basis moved from US$49.5 million in Q4 2024 to US$46.5 million in Q4 2025 while trailing EPS went from US$3.61 to US$2.18, setting the scene for a story where margins and earnings quality sit firmly in...

Marti Technologies (NYSEAM:MRT) has opened FY 2025 with first half revenue of US$14.3 million and a basic EPS loss of US$0.26, setting a cautious tone for investors watching the company’s path toward better profitability. The business has seen revenue move from US$8.4 million in the first half of 2024 to US$10.3 million in the second half of 2024 and then to US$14.3 million in the latest half, while EPS losses shifted from US$0.38 to US$0.87 and now US$0.26. As a result, the market will be...

Euronet Worldwide has recently attracted attention as a profitable, cash-generating payments and money transfer company that some commentators view as undervalued relative to peers, while also seeking shareholder approval to expand its stock incentive plan and refresh its board at a past annual meeting. An interesting development is the company’s shift to fully performance-based executive equity awards tied to operating income, earnings growth and stock price metrics, aligning management...

Genius Sports Limited recently appointed Tony Marlow as Chief Marketing Officer to lead its global marketing, communications, and brand strategy across sports, betting, media, and advertising clients, while the company also faces a lawsuit alleging its NFL-related technology contributes to addictive gambling behaviors. This combination of leadership investment and heightened legal scrutiny underscores how Genius Sports is simultaneously building its brand and defending its role in the...